New York City-based Memorial Sloan Kettering Cancer Center plans to implement Abridge’s AI platform across its system in 2025 and 2026.
The platform transcribes medical conversations into real-time, billable notes, allowing clinicians to spend less time on documentation and more time with patients, according to a March 5 news release.
The expansion follows a pilot program in which clinicians across cancer specialties found the platform accurately captured complex medical terms, including disease names and treatments. It also demonstrated strong performance in Spanish, Chinese, and Russian, according to the release.
Lawrence (Kan.) Memorial Hospital confirmed a patient privacy breach that occurred in 2023, affecting fewer than 0.004% of its patients,…
Health IT leaders are accountable for identifying and implementing technology to support the health system’s mission and teams. They are…
Oracle Health, the nation’s second-largest EHR vendor by market share, has been welcoming new customers into the fold in 2025.…
Comments are closed.
